These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33149619)

  • 1. Targeting Yes1 Associated Transcriptional Regulator Inhibits Hepatocellular Carcinoma Progression and Improves Sensitivity to Sorafenib: An in vitro and in vivo Study.
    Guo L; Zheng J; Luo J; Zhang Z; Shao G
    Onco Targets Ther; 2020; 13():11071-11087. PubMed ID: 33149619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [YAP regulates the proliferation and modifies the sensitivity to sorafenib in hepatocellular carcinoma cells].
    Guo LW; Shao GL; Luo J; Hao WY; Yao Z; Zheng JP
    Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):818-823. PubMed ID: 30481931
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way.
    Fang S; Zheng L; Chen X; Guo X; Ding Y; Ma J; Ding J; Chen W; Yang Y; Chen M; Zhao Z; Tu J; Ji J
    Hepatol Int; 2023 Dec; 17(6):1500-1518. PubMed ID: 37460832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET.
    He Q; Lin Z; Wang Z; Huang W; Tian D; Liu M; Xia L
    Oncogene; 2020 Dec; 39(50):7279-7295. PubMed ID: 33046796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1.
    Wang J; Li H; Xia C; Yang X; Dai B; Tao K; Dou K
    Onco Targets Ther; 2019; 12():869-882. PubMed ID: 30774374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc finger protein 703 induces EMT and sorafenib resistance in hepatocellular carcinoma by transactivating CLDN4 expression.
    Wang H; Xu H; Ma F; Zhan M; Yang X; Hua S; Li W; Li Y; Lu L
    Cell Death Dis; 2020 Apr; 11(4):225. PubMed ID: 32269215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huaier Restrains Proliferative and Migratory Potential of Hepatocellular Carcinoma Cells Partially Through Decreased Yes-Associated Protein 1.
    Shan L; Li Y; Jiang H; Tao Y; Qian Z; Li L; Cai F; Ma L; Yu Y
    J Cancer; 2017; 8(19):4087-4097. PubMed ID: 29187885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.
    You A; Cao M; Guo Z; Zuo B; Gao J; Zhou H; Li H; Cui Y; Fang F; Zhang W; Song T; Li Q; Zhu X; Yin H; Sun H; Zhang T
    J Hematol Oncol; 2016 Mar; 9():20. PubMed ID: 26957312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
    Wei JC; Meng FD; Qu K; Wang ZX; Wu QF; Zhang LQ; Pang Q; Liu C
    Acta Pharmacol Sin; 2015 Feb; 36(2):241-51. PubMed ID: 25557114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Noncoding RNA MALAT1 Contributes to Sorafenib Resistance by Targeting miR-140-5p/Aurora-A Signaling in Hepatocellular Carcinoma.
    Fan L; Huang X; Chen J; Zhang K; Gu YH; Sun J; Cui SY
    Mol Cancer Ther; 2020 May; 19(5):1197-1209. PubMed ID: 32220970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
    Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
    Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1.
    Zhang H; Liu H; Bi H
    Oncol Rep; 2017 Aug; 38(2):843-849. PubMed ID: 28677785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroartemisinin inhibited interleukin-18 expression by decreasing YAP1 in hepatocellular carcinoma cells.
    Gong Y; Peng Q; Gao Y; Yang J; Lu J; Zhang Y; Yang Y; Liang H; Yue Y; Shi X
    Acta Histochem; 2023 May; 125(4):152040. PubMed ID: 37119608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin Y Modulates the Proliferation, Invasion, and Metastasis of Hepatocellular Carcinoma Cells.
    Shi K; Ru Q; Zhang C; Huang J
    Med Sci Monit; 2018 Mar; 24():1642-1653. PubMed ID: 29557391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
    Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL
    Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.
    Tan W; Lim SG; Tan TM
    World J Gastroenterol; 2015 Dec; 21(46):13030-41. PubMed ID: 26676187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target.
    Xue ST; Li K; Gao Y; Zhao LY; Gao Y; Yi H; Jiang JD; Li ZR
    Autophagy; 2020 Oct; 16(10):1823-1837. PubMed ID: 31986961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
    Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.